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Abstract  
 
In this paper a series of simple lactam esters and carboxylic acids is studied with respect to 
their overall conformation and hydrogen bonding patterns. In total, eight lactams featuring Nα-
substitution have been synthesized. Additionally, the molecular structures of related lactam 
esters have been considered. The length of the amide bonds does not seem to be majorly 
influenced by different substituents unless the electron withdrawing N-Boc-protection group is 
introduced, resulting in a higher susceptibility towards hydrolytic ring opening. As known from 
other lactams, the Nα ester moiety of the title compounds can be in an axial or equatorial 
conformation. Smaller ester groups were found to prefer equatorial positions, while larger ones 
occupy axial sites. N-substitution seems to promote axial conformations of the respective Nα 
group, with enantholactams being the only studied exception. In addition to the two common 
amide packing motifs, i.e. the R2
2(8) amide dimer (NH∙∙∙O/NH∙∙∙O) and the C(4) amide chain, 
a third graph-set was found: the R2
2(8) NH∙∙∙O/CH∙∙∙O=C heterodimer. In general, there seems 
to be a tendency for medium-sized lactams as well as lactams with small esters to form R2
2(8) 
amide dimers. Larger esters and enantholactam esters lead to C(4) amide chains. In this respect 
the formation of R2
2(8) N-H∙∙∙O/C-H∙∙∙O=C heterodimers should be seen as a remarkable 
exception.  
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INTRODUCTION 
 
   Lactams, i.e. cyclic amides, are a prominent class of heterocycles and can be considered as 
oxo derivatives of the respective cyclic amines. However, their trivial names are used much 
more commonly (Figure 1). For many years lactams have widely been employed in industry1 ,2  
and in the synthesis of more advanced compounds.3-6 Moreover, lactams occur in natural 
products chemistry7,8 and are deployed as final APIs with the β-lactam antibiotics as the most 
prominent example.9 Despite being first described over one century ago, research on physical 
and chemical properties of lactams is still highly rewarding. Studies on their reactivity, 
thermodynamic and kinetic stability and their conformational behavior contribute not only to 
chemistry, though also to adjacent disciplines like material science and biology. A typical 
characteristic of lactams is the existence of cis and trans forms resulting from different dihedral 
angles of the amide bond.10 As observed for open amides, lactams also possess partial C-N 
double bond character, which goes in hand with resonance stabilization. While the amide bond 
lengths for small and medium-sized lactams (ring sizes 4-9) are rather consistent,11 their 
hydrolytic stability is not with the four and six membered rings being hydrolyzed significantly 
faster.12  
 
 
 
Figure 1. Nomenclature of small and 
medium sized lactams (trivial names). 
 
   Comparative studies on monocyclic lactams and especially simply substituted derivatives are 
unsatisfyingly rare.13-18 As part of our ongoing studies on bridged lactams19 we became 
interested in a series of small and medium-sized lactams featuring a carboxylic acid or a 
respective ester in the Nα position. In detail we discuss here the synthesis and the X-ray 
structures of pyroglutamates 1 (iso-propylester) and 2 (tert-butylester), pyrohomoglutamic acid 
methyl ester (3) and its respective acid (4), the Nα disubstituted caprolactam20-25 5 and the three 
enantholactam26,27 esters 6-8 (Figure 2); additionally, we deliver full analytica l 
characterization. Some of the title compounds are already known as useful building blocks 
and/or are part of biologically active compounds, such as pyroglutamic acid,28,29 iso-propyl 
pyroglutamate (1),30-32 tert-butyl pyroglutamate (2)33-37 and pyrohomoglutamic acid (4)38,39 and 
enantholactam 7.40    
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Figure 2. Title compounds 1-8. 
  
   The aim of this study was to learn how the ring size of the respective lactam and the nature 
of the carboxyl pendant affect the overall conformation and the hydrogen bonding pattern in 
the crystal packing. In general, R2
2(8) amide dimers and C(4) chains are typical graph-set 
descriptors found in lactam structures. However, for some title compounds we found 
alternative supramolecular synthons. For comparison reasons, we also included the molecular 
structures of related lactam derivatives in our considerations. As a result, we are able to present 
a comprehensive study on the solid state behavior of this synthetically useful type of compound 
and discuss the general influence of ring size and substitution pattern on the COOH and COOR 
moieties at the Nα position of lactams. The respective moieties can either adopt an axial or an 
equatorial site, which is of crucial importance for their reactivity e.g. in transannular cycliza t ion 
reactions.19,41,42 For steric reasons only ester groups in axial positions will allow such 
conversions (Figure 3). Despite the axial and the equatorial conformation are connected via 
equilibrium in solution, the molecular structures of the title compounds deliver valuable 
insights into their reactive conformation and give most beneficial information on distances and 
interactions in and between the molecules.  
 
 
 
Figure 3. Dieckmann reaction of caprolactam esters  as a reported example 
of a trannsannular cyclization.19  
 
 
EXPERIMENTAL SECTION 
 
   Synthesis of lactams 1-8. Butyrolactams 1 and 2 were synthesized from pyroglutamic acid 
and the respective alcohol via Steglich esterification. By way of interest, the iso-propyl ester 
could be isolated in a much higher yield than the respective tert-butyl ester (68 % vs. 9 %). The 
respective methyl ester (3) was prepared by direct cyclization of 2-aminoadipic acid in 
methanol and thionylchloride (58 % yield); saponification resulted in lactam acid 5 (79 %) 
(Scheme 1a). Title compounds 5-7 were synthesized via Schmidt rearrangement43,44 from the 
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respective cycloketones (9-11)45-48 in moderate to good yields (35-72 %) (Scheme 1b). N-Boc-
protection of ethyl ester 7 gave enantholactam 8 in 83 % yield. When we tried to saponify the 
Boc-protected caprolactam 1249 using LiOH/H2O2, ring opening was observed and the 
respective Boc-protected adipic acid 13 could be recovered (Scheme 1c).  
 
Scheme 1. (a) Syntheses of Valerolactams 3 and 4. (b) Syntheses of 
Lactams 5-7 via Schmidt reaction. (c) Hydrolysis of Boc-protected 
caprolactam 12.a    
 
(a) 
 
  
(b) 
 
  
(c) 
 
  
 
a Reaction conditions: (i) MeOH, SOCl2, rt; (ii) LiOH, H2O2, 
THF/H2O (1:1), rt; (iii) NaN3, H2SO4, CHCl3, 50 °C. 
 
 
   Materials and methods. Melting points were determined on a Zeiss Axio Vision microscope 
fitted with a Linkam THMS600 stage. Infrared spectra were recorded on a PerkinElmer 
Spectrum 100 FT-IR spectrometer. All wave numbers are given in cm-1. Mass spectra were 
recorded on a TSQ Endura Mass Spectrometer. High-resolution mass spectra were recorded on 
a Thermo Exactive Plus Orbitrap Mass Spectrometer with a Dionex UltiMate 3000 Quaternary 
RSLCnano System. Proton (1H, 500 MHz) and carbon (13C, 125 MHz) nuclear magnetic 
resonance experiments were performed on a Bruker Avance 500. NMR samples were prepared 
in CDCl3 and MeOD-d4 using TMS as an internal chemical shift standard. Reactions were 
followed with TLC (254 µm SiO2 60-F), visualization accomplished by KMnO4-staining. 
Column chromatography was performed on 230-400 mesh, 0.063-0.040 mm).  
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All reactions that required water free reaction conditions were performed under a nitrogen 
atmosphere. Dry solvents were purified over activated aluminum oxide. Commercia l ly 
available starting materials were used as received by Fluorochem. Ethyl 1-methyl-2-
cyclohexanonecarboxylate (9) was synthesized from ethyl 2-cyclohexanone-carboxyla te, 
methyl iodide and potassium carbonate according to a literature procedure.45 Methyl47 (10) and 
ethyl 7-cycloheptanonecarboxylate48 (11) were synthesized from cycloheptanone using the 
respective dialkylcarbonate and sodium hydride. The synthesis of caprolactam ester 12 has 
been described earlier.19 
   Preparation of pyroglutamates 1 and 2 (Steglich esterification). Commercially availab le 
pyroglutamic acid (1 eq.) was dissolved in dry CH2Cl2 (10 ml) followed by the addition of 4-
dimethylaminopyridine (DMAP, 100 mg, 0.82 mmol) and the respective alcohol (4 eq.). The 
mixture was cooled to 0 °C and N,N'-dicyclohexylcarbodiimide (DCC, 1.6 g, 7.75 mmol) were 
added. The mixture was stirred for 24 h. The resulting suspension was filtered and the filtra te 
washed with 0.5M hydrochloric acid. The organic layer was dried over MgSO4, concentrated 
in vacuo and purified by column chromatography (cyclohexane : EtOAc = 2 : 1) to give the 
desired esters.  
   (RS)-iso-Propyl pyroglutamate (1). Synthesized using 1.0 g of the starting material. Yield: 
900 mg (5.26 mmol, 68 %); white crystalline solid. TLC: Rf = 0.31 (EtOAc). Mp = 86 °C.  
   (RS)-tert-Butyl pyroglutamate (2). Synthesized using 1.0 g of the starting material. Yield: 119 
mg (0.64 mmol, 9 %); white crystalline solid. TLC: Rf = 0.26 (EtOAc). Mp = 97 °C; lit.50: 93 
°C (ether/petrolether).  
Full analytical data of the respective (S)-enantiomers of 1 and 2 can be found in the literature.5 1  
   (RS)-Methyl 6-oxo-piperidinecarboxylate (3). Methanol (40 ml) was cooled to -10 °C 
before adding thionylchloride (3.4 ml, 17.4 mmol), followed by the addition of commercia l ly 
available 2-aminoadipic acid (1.00 g, 6.88 mmol). The resulting mixture was stirred overnight, 
the solvent removed in vacuo and the residue dissolved in saturated aq. NaHCO3. The aqueous 
phase was extracted three times with ethyl acetate, dried over MgSO4 and the solvent removed 
in vacuo to give the desired product as a viscous oil, which crystallized after several days at 
room temperature. Yield: 572 mg (4.00 mmol, 58 %); white crystalline solid. TLC: Rf = 0.23 
(EtAOc). Mp = 65 °C. Full analytical data of the (S)-enantiomer of 3 can be found in the 
literature.52  
   (RS)-6-Oxopiperidinecarboxylic acid (4). Methyl ester 3 (300 mg, 1.91 mmol) was 
dissolved in a mixture of THF (15 ml) and water (15 ml). Subsequently, LiOH (183 mg, 7.64 
mmol) was added, followed by H2O2 (30 % in water, 65 μl, 2.10 mmol). The mixture was 
stirred for 24 h, then the pH adjusted to 3 with 0.5M hydrochloric acid and extracted three times 
with ethyl acetate. The combined organic layers were dried over MgSO4 and the solvent was 
removed in vacuo to give a viscous, colorless oil, which crystallized after several hours to a 
crystalline product. Yield: 217 mg (1.52 mmol, 79 %). Mp = 178 °C; lit.53: 178-179 °C. 1H 
NMR: (500 MHz, MeOD-d4) δ 3.99 (t, 3J = 6.3 Hz, 1H, H1), 2.40 (t, 3J = 7.2 Hz, 2H, H4), 
2.05-1.89 (m, 2H, H3, H2), 1.85-1.67 (m, 2H, H3’, H2’). 13C NMR: (125 MHz, MeOD-d4) δ 
175.1 (C5), 170.1 (C6), 52.3 (C1), 32.6 (C4), 29.5 (C2), 20.0 (C3). IR (ATR) νmax: 3202 
(CONH); 2933 (CH-aliphatic); 1720 (C=O, ester); 1642 (C=O, lactam); 1582; 1489; 1453; 
1408; 1372; 1329; 1297; 1246; 1222; 1172; 1098; 1036; 940; 873; 799; 765; 737; 710; 620; 
538; 495. HR-MS: calculated 144.0655 g/mol [MH]+, found 144.0643 g/mol. 
   General synthetic procedure for the synthesis of lactams 5-7 (Schmidt reaction). The 
respective ketone (1 eq.) was dissolved in CHCl3 (30 ml), followed by the addition of 
concentrated H2SO4 (15 ml). Finally, sodium azide (1.2 eq.) was added carefully. The mixture 
was then stirred gently and heated to 50 °C for 6 h. The cooled mixture was poured on crushed 
ice (200 g) and concentrated aq. NH3 was added until the aqueous phase reacted basic. The 
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layers were separated and the aqueous layer was washed three times with CHCl3. The combined 
organic layers were dried over MgSO4, the solvent was removed in vacuo and the residue was 
purified using column chromatography [SiO2; ethyl acetate] to give the desired lactams 5-7.  
   Ethyl 2-methyl-7-oxoazepanecarboxylate (5). Synthesized using 1.40 g ethyl 1-methyl-2-
cyclohexanonecarboxylate (9) as starting material. Yield: 1.12 g (5.62 mmol, 74 %); off-white 
crystalline solid. TLC: Rf = 0.28 (EtOAc). Mp = 96.0°C. 1H NMR: (500 MHz, CDCl3) δ 6.13 
(br s, 1H, NH); 4.25 (q, 3J = 7.1 Hz, 2H, H9); 2.55-2.50 (m, 1H, H3); 2.37-2.26 (m, 2H, H6, 
H3’); 1.92-1.87 (m, 1H, H4); 1.76-1.68 (m, 2H, H6’, H5); 1.61-1.54 (m, 2H, H4’, H5’); 1.49 (s, 
3H, H11); 1.31 (t, 3J = 7.1 Hz, 3H, H10). 13C NMR: (125 MHz, CDCl3, δ [ppm]) 177.6 (C2); 
173.8 (C8); 61.8 (C9); 59.7 (C7); 39.1 (C6); 37.6 (C3); 28.3 (C11); 26.4 (C5); 22.9 (C5); 14.2 
(C10). IR (ATR) νmax: 3198 (CONH); 3087 (CONH); 2974 (CH-aliphatic); 2936 (CH-
aliphatic); 2859 (CH-aliphatic); 1730 (C=O ester); 1661 (C=O lactam); 1579; 1456; 1411; 
1382; 1360; 1343; 1311; 1290; 1261; 1215; 1174; 1152; 1121; 1093; 1057; 1038; 1006; 954; 
889; 879; 837; 803; 769; 757; 735; 718; 693; 656; 620; 576; 547; 510; 462. HR-MS: calculated 
200.1286 g/mol [M+H]+, found 200.1264 g/mol. 
   Methyl 8-oxoazocanecarboxylate (6). Synthesized using 1.0 g methyl 2-cycloheptanone-
carboxylate (10) as starting material. Yield: 442 mg (2.39 mmol, 35 %); off-white crystalline 
solid. TLC: Rf = 0.37 (EtOAc). Mp = 89 °C; lit.54: 80-82 °C. 1H NMR: (500 MHz, CDCl3, δ 
[ppm]) 6.05 (br d, 1H, NH); 4.31-4.26 (m, 1H, H8); 3.79 (s, 3H, H10); 2.44-2.35 (m, 2H, H3, 
H3’); 2.05-1.99 (m, 1H, H7); 1.92-1.72 (m, 4H, H5, H6, H4, H4’); 1.68-1.61 (m, 1H, H7’); 
1.57-1.42 (m, 2H, H5’, H6’). 13C-NMR: (125 MHz, CDCl3, δ [ppm]) 175.3 (C2); 172.1 (C9); 
54.9 (C10); 52.7 (C8); 36.2 (C3); 33.6 (C7); 27.9 (C4); 25.8 (C5); 24.2 (C6), IR (ATR) νmax: 
3365 (CONH); 2922 (CH-aliphatic); 2856 (CH-aliphatic); 1732 (C=O ester); 1650 (C=O 
lactam); 1488; 1429; 1397; 1362; 1334; 1309; 1256; 1216; 1158; 1030; 981; 951; 911; 887; 
873; 822; 791; 765; 747; 720; 677; 638; 570; 516. HR-MS: calculated 186.1130 g/mol [M+H]+, 
found 186.1110 g/mol. 
   Ethyl 8-oxoazocanecarboxylate (7). Synthesized using 1.0 g ethyl 2-cycloheptanone-
carboxylate (11) as starting material. Yield: 627 mg (3.15 mmol, 54 %); viscous, colorless oil, 
which slowly crystallizes. Rf = 0.23 (EtOAc). Mp = 91 °C; lit.55: 96-98 °C. 1H NMR: (500 
MHz, CDCl3) δ  6.02 (br d, 1H, NH); 4.28-4.22 (m, 3H, H1, H9); 2.4-2.38 (m, 2H, H6, H6’); 
2.02-2.00 (m, 1H, H2); 1.88-1.75 (m, 4H, H3, H4, H5, H5’); 1.64-1.47 (m, 3H, H4’, H3’, H2’), 
1.30 (t, 3J = 7.2 Hz, 3H, H10), 13C NMR: (125 MHz, CDCl3) δ 175.3 (C7); 171.6 (C8); 61.9 
(C9); 55.0 (C1); 36.3 (C6); 33.6 (C2); 27.9 (C5); 25.8 (C3); 14.1 (C10) IR (ATR) 3311 
(CONH); 2937 (CH-aliphatic); 2867 (CH-aliphatic); 1730 (C=O ester); 1614 (C=O lactam); 
1467; 1447; 1362; 1350; 1322; 1289; 1260; 1242; 1221; 1184; 1160; 1095; 1061; 1017; 947; 
915; 800; 770; 753; 713; 654; 572; 513; 502, HR-MS: calculated 200.1281 g/mol [M+H]+, 
found 200.1281 g/mol.  
   1-tert-Butyl 2-ethyl 8-oxoazocane-1,2-dicarboxylate (8). Enantholactam 7 (2.00 g 10 
mmol) was dissolved in dry toluene (50 ml). DMAP (200 mg, 1.64 mmol), Boc2O (6.55 g, 30 
mmol) and N,N-diisopropylethylamine (DIPEA, 2.44 ml, 14 mmol) were added before the 
mixture was refluxed for 6 h. Subsequently, the reaction was quenched with water (15 ml). The 
layers were separated and the aqueous layer was extracted three times with toluene. The 
combined organic layers were dried over MgSO4, the solvent was removed in vacuo and the 
residue was purified using column chromatography [cyclohexane : EtOAc, 4 : 1] to give a 
yellow viscous oil, which crystallized after several days. Yield: 2.47 g (8.25 mmol, 83 %). Rf 
= 0.16 (cyclohexane : EtOAc = 1 : 4). Mp = 98 °C. 1H NMR: (500 MHz, CDCl3) δ 4.58 (dd, 
Jd = 4.5 Hz, Jdd = 12.3 Hz, 1H, H1); 4.21 (qq, 2Jq = 7.1 Hz; 3Jqq = 21.3 Hz; 2H, H9); 2.79-2.73 
(m, 1H, H6); 2.58-2.53 (m, 1H, H6’); 2.25-2.18 (m, 1H, H2); 2.08-2.00 (m, 1H, H2); 1.96-1.90 
(m, 1H, H5); 1.83-1.67 (m, 3H, H5’, H4, H3); 1.51 (s, 9H, H13, H14, H15); 1.45-1.37 (m, 2H, 
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H4’, H3’); 1.28 (t, 3J = 7.1 Hz, 3H, H10), 13C NMR: (125 MHz, CDCl3) δ 177.0 (C7); 170.3 
(C8); 151.9 (C11); 83.4 (C12); 61.5 (C9); 58.3 (C1); 38.1 (C6); 30.8 (C2); 29.1 (C5); 28.0 
(C13, C14, C15); 27.1 (C4); 24.2 (C3); 14.1 (C10), IR (ATR): 2980 (CH-aliphatic); 2942 (CH-
aliphatic); 2865 (CH-aliphatic); 2334; 1745 (C=O ester); 1713 (C=O carbamate); 1699 (C=O 
lactam); 1464; 1448; 1394; 1367; 1354; 1331; 1315; 1293; 1279; 1260; 1200; 1149; 1125; 
1109; 1083; 1047; 1022; 988; 955; 932; 897; 850; 818; 766; 743; 708; 674; 592; 549; 526; 479, 
HR-MS: calculated 322.1630 g/mol [M+Na]+, found 322.1623 g/mol. 
   2-[[(1,1-dimethylethoxy)carbonyl]amino]heptanedioic acid (13). 1-tert-Butyl 2-methyl 7-
oxoazepane-1,2-dicarboxylate (1.02 g, 3.57 mmol) was dissolved in 25 ml THF, LiOH (0.34 
g, 14.2 mmol) dissolved in 25 ml water and 3.5 ml of H2O2 (30 % in water) were added and 
the resulting suspension was stirred for 24 h. The pH was adjust to 3 with 1M HCl solution and 
aqueous solution was extracted three times with EtOAc. The combined organic layers were 
dried over MgSO4, the solvent was removed in vacuo to give the desired product as a white, 
crystalline solid. Yield: 0.748 g (2.72 mmol, 78 %). Mp = 118 °C (decomposition). 1H NMR: 
(500 MHz, MeOH-d4) δ 4.06 (dd, Jd = 4.8 Hz, Jdd = 8.9 Hz, 1H, H2); 2.30 (t, 3J = 7.4 Hz, 2H, 
H6); 1.82-1.79 (m, 1H, H3); 1.65-1.62 (m, 3H; H5, H3’); 1.44-1.43 (m, 11H, H4, H1013C 
NMR: 176.0 (C1); 174.9 (C7); 156.8 (C8); 80.0 (C9); 53.5 (C2); 33.3; 31.2 (C3, C6); 27.3 
(C10); 25.1; 24.2 (C4; C5). IR (ATR) νmax: 3324 (CONH); 2976 (CH-aliphatic); 2936 (CH-
aliphatic); 2859 (CH-aliphatic); 1729 (C=O ester); 1678 (C=O lactam); 1645; 1531; 1454; 
1395; 1368; 1298; 1280; 1254; 1215; 1159; 1106; 1068; 1051; 1014; 886; 852; 819; 784; 762; 
743; 684; 626; 579; 535; 459. HR-MS: calculated 276.1442 g/mol [M+H]+, found 276.1424 
g/mol. Some analytical data of the respective L-enantiomer of 13 has already been described in 
the literature.56 
 
   Structural characterization. Crystals of 1, 2, 5, 6 and 8 suitable for X-ray Diffraction were 
prepared by slow solvent evaporation of the respective solutions in ethyl acetate (1, 2, 5, 6) or 
methanol (8). Compounds 3, 4, 7 and 13 were recovered as oils, which produced crystals 
suitable for X-ray diffraction after several days. Single crystal X-ray diffraction was performed 
at 173 K with a Bruker D8 Venture diffractometer using a Cu-Kα source. Structure solution 
was carried out with shelxs57 and structure refinement with shelxl57 was finished using 
ShelXle58 software. For selected crystallographic and structural refinement parameters, 
molecular torsion angles and information regarding non-covalent interactions see Tables S1-
S7, Supporting Information.The crystallographic data for the structures in this paper have been 
deposited with the Cambridge Crystallographic Data Centre; CCDC numbers: 1839816 (1), 
1839824 (2), 1839823 (3), 1839820 (4), 1839817 (5), 1839818 (6), 1839819 (7), 1839821 (8), 
1872073 (13).  
 
 
RESULTS AND DISCUSSION 
 
   Butyrolactams 1 and 2. In this series we synthesized four esters of pyroglutamic acid, viz. 
methyl,59 ethyl,60 iso-propyl (1) and tert-butyl (2). The methyl and ethyl ester could only be 
recovered as oils, while 1 and 2 could be crystallized, followed by the determination of their 
X-ray struture. iso-Propylester 1 adopts a slight envelope conformation with C2 deviating from 
the C4-N1-C1-C2 mean plane by 0.1962(19) Å (Figure 4a); this is quite low compared to the 
parent lactam (0.371 Å) (CSD code: NILYAI).61 The ester group of 1 is in an axial position, 
though it is debatable if a C4-N1-C1-C5 angle of -125.58(10) ° justifies the differentiation into 
axial/equatorial in this specific case.  
   In the packing, two molecules of 1 related via an inversion center form an R2
2(8) amide dimer 
via N-H∙∙∙O hydrogen bonds. These typical arrangements, which are also found in the 
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respective parent lactam, are interconnected via C-H∙∙∙O interactions between C3 and the 
carbonyl oxygen featuring the graph set descriptor R2
2(8) (Figure 4b). 
 
 
a) 
 
 
b) 
 
Figure 4. Molecular structure of iso-propyl 
ester 1 (a) and its packing diagram (b). 
Hydrogen bonds (orange) and C-H∙∙∙O 
contacts (black) are shown as broken lines.  
 
   The tert-butyl ester of pyroglutamic (2) crystallizes in the monoclinic space group; an 
orthorhombic polymorph of 2 has been described earlier (CSD code: DICXET).62 The 
asymmetric unit of the polymorph described here consists of one molecule in an envelope 
conformation, which is much more pronounced than those of the isopropyl ester (1). Carbon 
C2 deviates by 0.329(3) Å from the C4-N1-C1-C2 mean plane (Figure 5a); for the 
orthorhombic polymorph an ever larger bend (0.412 Å) is observed. The tert-butyl ester groups 
of 2 adopts an axial position with a C4-N1-C1-C5 angle of -102.50(16) °, which is comparable 
to the polymorph (100.4 °) (Figure 5b). As expected, the methyl groups of the tert-butyl units 
avoid an eclipsed conformation with respect to the carbonyl group; this arrangement results in 
two intramolecular C-H∙∙∙O contacts.  
   The packing of tert-butyl ester 2 differs significantly from the one of the iso-propyl ester (1) 
discussed above. In both polymorphs of 2, the amide units are engaged in C(4) chains 
consisting of N-H∙∙∙O hydrogen bonds; the strength of the interaction is thereby comparable 
with those of 1. The N-H∙∙∙O chains are further connected by two C-H∙∙∙O contacts involving 
C1∙∙∙O1 and C3∙∙∙O3 featuring the graph-set descriptor R2
2(8). The resulting molecular bands 
are linked to their neighbors via a weaker C-H∙∙∙O contact. Towards the crystallographic a axis 
the molecular bands display hydrophobic interactions from the tert-butyl residues giving a 
layered overall packing (Figure 5c). When comparing the packing of 1 and both polymorphs 
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of 2, the R2
2(8) C-H∙∙∙O dimers occur in all three packing diagrams, despite the generally more 
dominant amide hydrogen bonding pattern is changing from 1 to 2 (Figure S1, Supporting 
Information). 
 
 
 
a) 
 
b) 
 
 
c) 
 
Figure 5. Molecular structure of tert-butyl ester 2 in the 
monoclinic polymorph (a) and the overlay of the 2 in the 
monoclinic (red) and orthorhombic space group (blue) 
(overlay of amide region) (b). Packing behavior of 2 
displayed in direction of the c axis.  
 
   Valerolactams 3 and 4. The amide region of methyl ester 3 is more or less planar with atoms 
C2 and C3 deviating from planarity by 0.359(2) Å for C2 and 0.395(2) Å for C3. The ester 
moiety is in a clear equatorial position (Figure 6a). As observed for the parent valerolactam 
(CSD code: HIQJOJ)11 two molecules of 5 form an R2
2(8) amide dimer via N-H∙∙∙O hydrogen 
bonds (Figure 6b). The dimerized lactams are connected via C-H∙∙∙O interactions between C4 
and the carbonyl oxygen forming bands in the direction of the b axis. Further interconnec tion 
occurs by rather weak C-H∙∙∙O contacts in the c direction and hydrophobic interactions between 
the bands (Fig. 6c).   
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a) 
 
b) 
 
 
c) 
 
Figure 6. Molecular structure (a) and dimer formation in 3 showing the 
R2
2(8) hydrogen bonding motif (b). When viewing the packing down the c 
axis a combination of strong N-H∙∙∙O and weaker C-H∙∙∙O hydrogen bonds  is 
evident; hydrophobic interactions have been shaded in grey (c). 
 
   The conformation of pyrohomoglutamic acid (4), i.e. the Nα carboxylic acid of valerolactam, 
is very similar to those of the parent compound. The molecule is in the typical half-chair with 
atoms C2 and C3 deviating from the amide mean plane by 0.463(3) and 0.278(3) Å. The COOH 
unit occupies an axial position (Figure 7a). In the packing of 4, two main interactions have 
been found: 1. The carboxylic acid is engaged in C(7) chains formed by strong O-H∙∙∙O 
hydrogen bonding interactions with the amide carbonyl. 2. These chains are interconnected by 
R2
2(8) amide dimers via N-H∙∙∙O hydrogen bonds. The latter are rather weak in comparison to 
those of the other lactams. This is not only expressed by the longer donor-acceptor distance, 
but also by the low angle of 152.2(16) °. It leads to a displacement of the participating amide 
regions of 0.872 Å (Figure 7b). In addition to the strong hydrogen bonds, the O-H∙∙∙O chains 
are further interconnected by two C-H∙∙∙O contacts with the graph set descriptor R2
2(8) for 
C4∙∙∙O3 and R3
2(9) for C1∙∙∙O2. The formed sheets are linked by two more C-H∙∙∙O contacts 
involving C1∙∙∙O1 and C2∙∙∙O3 (Figure 7c).  
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a) 
 
b) 
 
 
c) 
 
Figure 7. a) Molecular structure of 4. b) Formation of displaced R2
2(8) dimers in  
4. c) Packing diagram featuring a combination of NH∙∙∙O and OH∙∙∙O hydrogen 
bonds. 
 
   The C(7) graph set descriptor featuring O-H∙∙∙O hydrogen bonds seems to be a rather 
dominating interaction for other pyrohomoglutamic acids and is also found in respective N-
alkylated species (CSD codes: WALWOY,63 LOQCOL,64 LOQCUR64). Even the loss of the 
amide proton does not change the strength of O-H∙∙∙O hydrogen bonds significantly (2.574-
2.560 Å).  
 
   Caprolactam 5. The conformational behavior of caprolactams is closely related to those of 
cycloheptene65, existing in a symmetrical (pseudo) chair, a symmetrical boat, a twist-boat and 
a biplanar form66, with the chair being lowest in energy. Caprolactam 5 occupies a chair and 
its conformation is only slightly deviating from the one known for the parent caprolactam (CSD 
code: CAPLAC67). The largest difference is observed for the C6-N1-C1-C2 torsion angle 
[59.3(2)° vs. 67.8 °] (Figure 8a). The additional Nα methyl group in 5 has also no significant 
influence on the amide bond length compared with the caprolactam methyl ester (CSD code: 
BOLHER49).  
   In 5, the ester pendant occupies an axial position. In the packing, R2
2(8) amide dimers 
connected via N-H∙∙∙O hydrogen bonds can be found (Figure 8b). By way of interest, the 
position of the ester supersedes its size in terms of direct influence on H bonding strength. With 
the ester moiety in an axial conformation such as in 5 or the monodesaturated methyl ester 
(CSD code: BOLJIX49) the N-H∙∙∙O distances are comparable to those in the parent 
caprolactam. For the caprolactam methyl ester (BOLHER) featuring an equatorial ester unit 
the dimerizing hydrogen bonds are significantly weaker. In the packing the lactam dimers are 
engaged in a series of C-H∙∙∙O contacts involving C2 and C5 and all three oxygen atoms (Figure 
8c) 
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a) b) 
 
c) 
 
Figure 8. a) Molecular structure of 5. b) Formation of displaced R2
2(8) 
dimers. c) Packing diagram of 5 featuring a combination of NH∙∙∙O and 
CH∙∙∙O hydrogen bonds. 
 
 
   Enantholactams 6-8. All title lactams have been synthesized in a symmetric synthesis, i.e. 
they occur as racemates in solution. In most cases this leads to the formation of racemic 
crystals. However, for enantholactams 6 and 8 we observed the formation of conglomerates.  
   The overall conformation of enantholactam methyl ester 6 is rather close to the one of the 
parent enantholactam (CSD code: ENANOL68) as demonstrated by the similar torsions angles. 
The ester pendant was found in an equatorial position (Figure 9a). In general, for 
(enantho)lactam derivatives two hydrogen bonding patterns can be found in the literature : 
R2
2(8) amide dimers69,70 and C(4) chains.71 However, in case of methyl ester 6 we found a third 
possible variation. The amide hydrogen is engaged in a quite weak N-H∙∙∙O hydrogen bond 
with the methoxy oxygen of the ester moiety (Figure 9b). This is rather unexpected since OMe 
oxygens are usually considered weaker acceptors than carbonyl oxygens, of which two can be 
found in the molecule. The amide carbonyl is engaged in a trifurcated C-H∙∙∙O contact (C1∙∙∙O1, 
C2∙∙∙O1, C6∙∙∙O1), whereas the ester carbonyl is involved in a bifurcated one (C6∙∙∙O2, 
C9∙∙∙O2). The donor-acceptor lengths of the trifurcated contact (four-center contact) found in 
6 are shorter and the respective DHA angles much larger than for related systems.72-74 The 
overall packing can be described as a combination of two R2
2(8) N-H∙∙∙O/C-H∙∙∙O=C 
heterodimers.   
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a) 
 
b) 
 
Figure 9. a) Molecular structure of methylester 6. b) 
The combination of discreet NH∙∙∙O hydrogen bonds 
and a series of CH∙∙∙O contacts in 6 is in contrast to the 
packing of the other title lactams.  
 
 
   Title compound 7 has two molecules in the asymmetric unit representing the two 
enantiomers; the conformations of both differ only slightly. A comparison of ethyl ester 7 to 
the parent lactam and methyl ester 6 shows distinct variations in their respective conformations 
with a difference in torsion angles of about 15-20 °. Moreover, the amide region is no longer 
coplanar as in ENANOL, though develops dihedral angles of -13.7(2) ° and 14.7(2) °, 
respectively. The COOEt unit is in an equatorial position for both molecules of the asymmetr ic 
unit (Figure 10a). As observed for the parent lactam the amide units of 7 are engaged in chains 
of strong N-H∙∙∙O hydrogen bonds best described with a C(4) graph descriptor, which is usually 
more typical for trans amides.75 By way of interest the DHA angle is much lower than observed 
for the unsubstituted enantholactam. In the overall packing of 7 the N-H∙∙∙O chains are 
interconnected by a series of weaker C-H∙∙∙O contacts. This includes a bifurcated contact 
(C11∙∙∙O2, C16∙∙∙O2), an R2
2(6) dimerization involving two ester groups (C9∙∙∙O6, C19∙∙∙O3) 
and a very weak carbonyl/ester linkage (C10∙∙∙O4, C20∙∙∙O1) (Figure 10b; Figure S2, 
Supporting Information).   
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a) 
 
 
b) 
 
Figure 10. a) Molecular structure of 7. b) Packing  
diagram of 7 featuring a combination of NH∙∙∙O 
hydrogen bonds and CH∙∙∙O contacts.  
 
   The introduction of the Boc group to enantholactam 7 does not change the equatorial position 
of the COOEt unit in title compound 8 unlike as observed for the smaller lactams. Though, the 
dihedral angle of the amide region increases to -27.9(3) °; the conformational changes in the 
rest of molecule are less pronounced (Figure 11a/b). Due to the lack of strong H bond donors 
the non-covalent interactions in the packing is reliant on a series of C-H∙∙∙O contacts (Figure 
11c).  
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a) 
 
b) 
 
c) 
 
Figure 11. a) Molecular structure of 8. b) Overlay of ethylester 7(1) (blue) and the 
respective bocated compound 8 (orange) (overlay of amide region). c) Packing 
diagram of 8 highlighting the intermolecular C-H∙∙∙O contacts. 
 
The relationship of the ester position and reactivity has studied for caprolactam ester 12 and 
enantholactam ester 8. While 12 featuring an axial ester undergoes a transannular Dieckmann 
cyclization when treated with the strong base lithium bis(trimethylsilyl)amide (LiHMDS),19 the 
enantholactam 8 with its equatorial ester shows no reaction. We suppose that the switch from 
axial (12) to equatorial (8) is a main reason for this behavior (Figure 12).  
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Figure 12. In comparison to caprolactam ester 12 
enantholactam ester 8 does not undergo a 
transannular Dieckmann cyclization reaction 
leading to a bicyclic system (cf. Figure 3).  
 
   Comparison of Nα carboxylated lactams. In order to put our findings in context to the 
literature, we analyzed published X-ray structures of related lactam acids and respective esters 
featuring a COOR (R=H, alkyl) in the Nα position (Figure 13). A comprehensive structural 
analysis can be found in the Supplementary Information (Table S3-S7, Supporting 
Information).  
 
 
     
PELJUM 76 PYRGLU0177 ABOQOA78 YAYMAO79 YEKQOX80 
     
     
CEVBUC81 WALWOY63 LOQCOL64 LOQCUR64 BAKYOC82 
     
     
BOLHIV49 BOLHER49 BOLJIX49 
BOLHOB49 (12) 
(polymorph I) 
BOLHOB0119 (12) 
(polymorph II) 
 
Figure 13. Reference compounds and their CSD refcodes. 
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   Butyrolactams. The envelope conformation of the butyrolactams discussed herein varies for 
different molecules, which is demonstrated by the broad range of deviation of carbon atom C2 
from the mean amide plane (7.4-28.4 °). For the free acid and the difluoroethyl ester the 
carboxyl pendant prefers an equatorial position, for larger esters and N-substituted 
butyrolactams (Bn, Boc) it occupies an axial position. The butyrolactams with smaller ester 
residues were found to crystallize as R2
2(8) amide dimers, those with larger ester residues as 
C(4) chains. Worth noting, esters of pyroglutamic acid have smaller Kitaigorodskii Packing 
Indeces (KPIs) than the free acid (72.6 %) and the respective parent lactam (71.8 %). 
   Valerolactams. The ethyl ester moiety of valerolactam takes an equatorial position, whereas 
in the free acid and in N-derivatized (aryl, heteroaryl, Boc) acids and esters the carboxylate is 
clearly axial. The highest KPI is observed for the methylester and free acid (both 73.5 %). The 
free valerolactam and the methyl ester is engaged in R2
2(8) amide dimers; the free acids are 
engaged in C(7) chains between amide carbonyl and OH group of the acid function.  
   Caprolactams. In the series of caprolactam carboxylates only the methyl ester and the acid 
were found as equatorial conformers; desaturation, second Nα substitution and N-derivatiza t ion 
lead to axial ester units. The highest KPI has been found for the methylester (72.4 %). Accept 
for the acid all other caprolactams studied here – all of them are small esters – form R2
2(8) 
dimers.  
   Enantholactams. Neither different ester residues (Me, Et) nor N-Boc-protection nor 
different packing modes seem to influence or change the equatorial COOR position. In 
comparison to the other lactams, the enantholactam esters have very similar torsion angles 
[149.11(4)-154.6(2) °], though their amide regions loose co-planarity with increasingly sized 
ester residues. The parent lactam and the ethyl ester form C(4) amide chains; for the methyl 
ester we were able to describe an alternative packing mode. The parent enantholactam has the 
highest KPI (70.7 %). 
   Full comparison of all lactams studied. It is worth noting that none of the lactams studied 
by X-ray diffraction in this paper contain solvents molecules. One possible explanation is the 
rather high degree of amide self-aggregation in solution,83 preventing strong interactions of the 
lactam with solvent molecules. The lengths of the amide bonds in the diverse ester derivatives 
only vary slightly (1.31-1.35 Å) – indifferently from ring size or carboxy substituent. The only 
exceptions are the N-Boc lactams (imides) with ‘amide bonds’ of 1.39 to 1.42 Å (Figure 14). 
The largest deviation from the parent lactam to ester is observed for the two Boc-caprolactam 
polymorphs of 12 (6.14 % / 6.68 %).  
   The longer amide bond in N-Boc protected amides may have influence on the synthet ic 
usability of the respective compounds. While the lactam ester BOLHER (Figure 12) – featuring 
an amide bond length of 1.347 Å – can be rather easily transferred into the free lactam acid  
using LiOH in THF/H2O,49 the longer amide bond in 12 may give rise to a hydrolytic ring 
opening under the same conditions (Scheme 1). (Details on the X-ray structure of the resulting 
diacid are given in the Supporting Information.) However, structural and hydrolytic studies for 
the unsubstituted parent lactams have shown, that not differences in the amide bond length are 
responsible for their varying hydrolytic behaviour.11,12 In fact, the formation of the tetrahedral 
intermediate – connected to the overall conformation of the lactam and potential substituents – 
was shown to be rate-determining not so much the fission of the C-N bond. So it cannot be 
ruled out that also the axial or equatorial position of the Nα substituent has on influence on the 
rate of lactam hydrolysis.  
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Figure 14. Comparison of the amide bond lengths in N-Boc 
protected esters of different ring sizes (orange) and the 
respective parent lactams (blue). (CSD codes and the alky l 
residues of the esters are shown.)  
 
   In the following we studied the influence of Nα carboxyl lactams substitution pattern on the 
position of COOR unit. There seems to be a tendency, that for ring sizes 5-8, smaller esters 
(Me, Et, Et(F)2) and the respective acids prefer an equatorial position (exception: valerolactam 
acid 4); larger ester (iPr, tBu) were found to occupy axial sites. For ring sizes 5-7 the N-
substitution leads an axial arrangement the COOR pendant, as also observed for desaturation 
and Nα methylation (for caprolactams). For all enantholactams studied the ester moiety 
occupied an equatorial position (Table 1).  
 
Table 1. Influence of the substitution pattern of Nα carboxyl lactams on the position of the COOR residue  
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5 6 7 8 
R1=iPr, R2=H 
R1=tBu, R2=H 
R1=H, R2=Bn(4-OH) 
R1=Et, R2=Bn(2-OH) 
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1
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1
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1
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R
1
=Me, R
2
=H 
(monodesaturated) 
R
1
=Et, R
2
=H 
(Nα methylated) 
R
1
=Me, R
2
=Boc 
--- 
 
   Also with respect to the hydrogen bonding systems we want to hypothesize that at least 
medium-sized free lactams (ring size 5-7) and small esters (Me, Et, Et(F)2, iPr) will form 
R2
2(8) amide dimers. Larger esters and enantholactam esters prefer C(4) chains. Such a switch 
from amide dimers to chains has already been observed for the parent lactams.11 The 
enantholactam methyl ester (6) should be seen as an exception in conjunction with the sizes 
of the lactam ring and the ester.  
20 
   For all lactam acids discussed here we found O-H···O chains involving the hydroxyl group 
of the acid and the amide carbonyl; C(7) has been found as a common graph-set motif. For 
lactam acids featuring free NH functions, additional C=O···HN hydrogen bonds lead to the 
cyclic motifs R3
3(13) (ring size: 4; PELJUM), R2
2(10) (ring size: 5; PYRGLU01) or R2
2(8) 
motifs (ring size: 6; 4) (Figure 15). The respective caprolactam acid is an exception: here the 
molecules are arranged R2
2(8) acid-amide heterodimers, which are typically only observed for 
amide/carboxylic acid co-crystals.84,85  
 
 
 
Figure 15. General hydrogen bonding motif found for Nα carboxylactams (except for 
the respective caprolactam). Depending on the nature of R, the C(7) chains are further 
interconnected: R ≠ H: no other strong hydrogen bonds; R = H: further interactions via 
N-H···O bonds.  
 
 
CONCLUSION 
 
   In this paper we presented a series of Nα substituted lactams esters and acids with respect to 
their overall conformation and hydrogen bonding pattern. In total, eight lactams have been 
synthesized and studied. In addition to the two literature-known amide packing motifs, i.e. 
R2
2(8) amide dimer and C(4) amide chain, a third graph-set was found: R2
2(8) N-H∙∙∙O/C-
H∙∙∙O=C heterodimers. Additionally, C(7) O-H···O chains has been pinpointed as a typical 
graph-set motif for the lactam acids. With respect to the overall packing of the lactam ester it 
can be stated that it is rather rich in C-H···O contacts. In most title compounds the slightly 
acidic carbon atom C1 is engaged in such contacts ranging from 3.226(3) Å (8) to 3.440(2) Å 
(2). This correlates with the importance of Cα-H···O contacts for the stability of protein 
structures.86  
   For comparison reasons, we also included a number of already published lactam esters and 
acids in our considerations. In general, it can be stated that none of the lactams’ X-ray structures 
contain solvents molecules. To our surprise, the length of the amide bonds does not seem to be 
majorly influenced by different substituents unless the electron withdrawing N-Boc-protection 
group is introduced. We also found a higher susceptibility towards hydrolytic ring opening, 
which may go in conjunction with the elongated amide bond. In general, Nα ester moieties have 
a preference to equatorial occupation for smaller ester as well as their free acids and axial 
occupation for larger ones. In the same way N-substitution leads to an axial arrangement the 
COOR pendant for ring sizes 5-7; in all enantholactam derivatives studied the ester units 
occupy equatorial positions. With regard to the crystal packing small esters of the medium-
sized lactams seem to prefer the formation of R2
2(8) amide dimers whereas larger esters and 
enantholactams form C(4) amide chains. In our opinion the formation of R2
2(8) N-H∙∙∙O/C-
H∙∙∙O=C heterodimers in 6 should be considered as exemption in lactams. We will test out this 
principle in further experiments in order to establish if the exception proves the rule or if N-
H∙∙∙O/C-H∙∙∙O=C heterodimers are recurrent synthons in lactam structures.  
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“Does the exception prove the rule? - A 
comparative study of supramolecular 
synthons in a series of lactam esters” 
 
C. Weck, E. Nauha, T. Gruber* 
 
 
 
 
A series of simple Nα-substituted lactam 
esters and carboxylic acids is studied with 
respect to bond length, overall 
conformation and hydrogen bonding 
pattern. In addition to the two common 
amide packing motifs, i.e. the R2
2(8) amide 
dimer (NH∙∙∙O/NH∙∙∙O) and the C(4) amide 
chain, a third graph-set was found: the 
R2
2(8) NH∙∙∙O/CH∙∙∙O=C heterodimer.  
 
 
 
 
 
 
